4KY1
| humanized HP1/2 Fab | Descriptor: | IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN, LIGHT CHAIN | Authors: | Arndt, J.W, Hanf, K.J.M, Lugovskoy, A, Chen, L.L, Jarpe, M, Boriack-Sjodin, A, Li, Y, van Vlijmen, H, Pepinsky, B, Taylor, F, Silvian, L, Taveras, A. | Deposit date: | 2013-05-28 | Release date: | 2013-07-24 | Last modified: | 2023-09-20 | Method: | X-RAY DIFFRACTION (2.97 Å) | Cite: | Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework. METHODS (SAN DIEGO), 65, 2014
|
|
2B2X
| VLA1 RdeltaH I-domain complexed with a quadruple mutant of the AQC2 Fab | Descriptor: | Antibody AQC2 Fab, Integrin alpha-1, MAGNESIUM ION | Authors: | Clark, L.A, Boriack-Sjodin, P.A, Eldredge, J, Fitch, C, Friedman, B, Hanf, K.J, Jarpe, M, Liparoto, S.F, Li, Y, Lugovskoy, A. | Deposit date: | 2005-09-19 | Release date: | 2006-04-18 | Last modified: | 2023-08-23 | Method: | X-RAY DIFFRACTION (2.2 Å) | Cite: | Affinity enhancement of an in vivo matured therapeutic antibody using structure-based computational design Protein Sci., 15, 2006
|
|
3HC4
| BHA10 IgG1 Fab quadruple mutant variant - antibody directed at human LTBR | Descriptor: | ACETATE ION, IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN, ... | Authors: | Arndt, J.W, Jordan, J.L, Lugovskoy, A, Wang, D. | Deposit date: | 2009-05-05 | Release date: | 2009-08-04 | Last modified: | 2023-09-06 | Method: | X-RAY DIFFRACTION (1.62 Å) | Cite: | Structural understanding of stabilization patterns in engineered bispecific Ig-like antibody molecules Proteins, 77, 2009
|
|
3HC0
| BHA10 IgG1 wild-type Fab - antibody directed at human LTBR | Descriptor: | ACETATE ION, IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN, ... | Authors: | Arndt, J.W, Jordan, J.L, Lugovskoy, A, Wang, D. | Deposit date: | 2009-05-05 | Release date: | 2009-08-04 | Last modified: | 2011-07-13 | Method: | X-RAY DIFFRACTION (1.9 Å) | Cite: | Structural understanding of stabilization patterns in engineered bispecific Ig-like antibody molecules Proteins, 77, 2009
|
|
3HC3
| BHA10 IgG1 Fab double mutant variant - antibody directed at human LTBR | Descriptor: | ACETATE ION, IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN, ... | Authors: | Arndt, J.W, Jordan, J.L, Lugovskoy, A, Wang, D. | Deposit date: | 2009-05-05 | Release date: | 2009-08-04 | Last modified: | 2024-10-16 | Method: | X-RAY DIFFRACTION (1.72 Å) | Cite: | Structural understanding of stabilization patterns in engineered bispecific Ig-like antibody molecules Proteins, 77, 2009
|
|
1D4B
| CIDE-N DOMAIN OF HUMAN CIDE-B | Descriptor: | HUMAN CELL DEATH-INDUCING EFFECTOR B | Authors: | Lugovskoy, A, Zhou, P, Chou, J, McCarty, J, Li, P, Wagner, G. | Deposit date: | 1999-10-02 | Release date: | 1999-12-17 | Last modified: | 2024-05-22 | Method: | SOLUTION NMR | Cite: | Solution structure of the CIDE-N domain of CIDE-B and a model for CIDE-N/CIDE-N interactions in the DNA fragmentation pathway of apoptosis. Cell(Cambridge,Mass.), 99, 1999
|
|
3KYK
| Crystal structure of li33 Igg1 Fab | Descriptor: | Heavy Chain Li33 IgG1, Light Chain Li33 IgG1, SULFATE ION | Authors: | Silvian, L.F, Pepinsky, R.B, Walus, L. | Deposit date: | 2009-12-06 | Release date: | 2010-03-16 | Last modified: | 2023-09-06 | Method: | X-RAY DIFFRACTION (3.2 Å) | Cite: | Improving the solubility of anti-LINGO-1 monoclonal antibody Li33 by isotype switching and targeted mutagenesis. Protein Sci., 19, 2010
|
|
3KYM
| Crystal structure of Li33 IgG2 di-Fab | Descriptor: | Heavy Chain Li33 IgG2, Light Chain Li33 IgG2 | Authors: | Silvian, L.F, Pepinsky, R.B, Walus, L. | Deposit date: | 2009-12-06 | Release date: | 2010-03-16 | Last modified: | 2024-10-16 | Method: | X-RAY DIFFRACTION (2.62 Å) | Cite: | Improving the solubility of anti-LINGO-1 monoclonal antibody Li33 by isotype switching and targeted mutagenesis. Protein Sci., 19, 2010
|
|
4IQK
| Crystal structure of cpd 16 bound to Keap1 Kelch domain | Descriptor: | Kelch-like ECH-associated protein 1, N,N'-naphthalene-1,4-diylbis(4-methoxybenzenesulfonamide) | Authors: | Silvian, L, Marcotte, D. | Deposit date: | 2013-01-11 | Release date: | 2013-05-15 | Last modified: | 2013-07-03 | Method: | X-RAY DIFFRACTION (1.97 Å) | Cite: | Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism. Bioorg.Med.Chem., 21, 2013
|
|
3BRV
| NEMO/IKKb association domain structure | Descriptor: | Inhibitor of nuclear factor kappa-B kinase subunit beta, NF-kappa-B essential modulator | Authors: | Silvian, L.F. | Deposit date: | 2007-12-21 | Release date: | 2008-04-22 | Last modified: | 2024-02-21 | Method: | X-RAY DIFFRACTION (2.2 Å) | Cite: | Structure of a NEMO/IKK-Associating Domain Reveals Architecture of the Interaction Site. Structure, 16, 2008
|
|
3BRT
| NEMO/IKK association domain structure | Descriptor: | Inhibitor of nuclear factor kappa-B kinase subunit beta,Inhibitor of nuclear factor kappa-B kinase subunit alpha, NF-kappa-B essential modulator | Authors: | Silvian, L.F. | Deposit date: | 2007-12-21 | Release date: | 2008-04-22 | Last modified: | 2024-02-21 | Method: | X-RAY DIFFRACTION (2.25 Å) | Cite: | Structure of a NEMO/IKK-Associating Domain Reveals Architecture of the Interaction Site. Structure, 16, 2008
|
|
4IN4
| Crystal structure of cpd 15 bound to Keap1 Kelch domain | Descriptor: | 2-({5-[(2,4-dimethylphenyl)sulfonyl]-6-oxo-1,6-dihydropyrimidin-2-yl}sulfanyl)-N-[2-(trifluoromethyl)phenyl]acetamide, Kelch-like ECH-associated protein 1, PHOSPHATE ION | Authors: | Silvian, L, Marcotte, D. | Deposit date: | 2013-01-03 | Release date: | 2013-05-15 | Last modified: | 2023-09-20 | Method: | X-RAY DIFFRACTION (2.59 Å) | Cite: | Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism. Bioorg.Med.Chem., 21, 2013
|
|